Clinical Trials Browser

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Phase NA Recruiting

83 enrolled

Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

45 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04213469 2024-01-05

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

Phase NA Completed

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT05376709 2023-07-27

A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population

Phase NA Unknown

200 enrolled

Lymphoid

Lymphoma, B-Cell

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Unknown

20 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT05619861 2022-11-17

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Phase NA Unknown

20 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Leukemia, T-Cell, Lymphoma, B-Cell

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

410 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Phase NA Unknown

18 enrolled

GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

NCT01541072 2016-11-01

PALM2

Phase NA Terminated

34 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT02813837 2016-06-28

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Phase NA Unknown

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01044004 2013-07-23

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Phase NA Withdrawn

Lymphoid

Fatigue, Lymphoma, B-Cell

Clinical Trials

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Anti CD19 Gene Therapy for B-cell Lymphoma

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

CELERITY

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

STAY-STRONG

EPC-MM+L

LONGSAFE

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

ECAR01

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

MargheRITA

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

CAR-T Cells in the Treatment of Malignant Hematological Tumors

ONCOPRO

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

PALM2

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue